Advertisement
Screener

REVELATION BIOSCIENCES, INC. (REVB) Prepaid Expense, Current

2.8 / 5 stars · 68/120 Roast Me

REVELATION BIOSCIENCES, INC. Prepaid Expense, Current

REVELATION BIOSCIENCES, INC. (REVB) had Prepaid Expense, Current of $4.83 thousand as of 2021-12-31, per its 10-K filed 2022-04-15.

Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current

us-gaap:PrepaidExpenseCurrent · last filed 2022-04-15

  • 2021-12-31: Prepaid Expense, Current $4.83K.
  • 2021-09-30: Prepaid Expense, Current $19.33K.
  • 2021-06-30: Prepaid Expense, Current $71.92K.
  • 2021-03-31: Prepaid Expense, Current $124.51K.
Period endPrepaid Expense, Current
2021-12-31$4.83K
10-K · filed 2022-04-15
2021-09-30$19.33K
10-Q · filed 2021-10-29
2021-06-30$71.92K
10-Q · filed 2021-08-23
2021-03-31$124.51K
10-Q · filed 2021-06-22
2020-12-31$114.27K
10-K · filed 2022-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
Onconetix, Inc. (ONCO)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Sunshine Biopharma Inc. (SBFM)$0.003B
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57